Avaliação da atividade biológica de triazenos inéditos complexados com Au(I)

Detalhes bibliográficos
Autor(a) principal: Kempfer, Cláudia Barbisan
Data de Publicação: 2013
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações do UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/6012
Resumo: The Triazenes are compounds with proven antibacterial and cytotoxic activity. Variations in the chemical structure such as complexation with metals like gold (I) can confer different biological activities. The antineoplastic temozolomide and dacarbazine are examples of commercially available triazenes used in the treatment of solid tumors and acute leukemias. In this study, the following compounds were synthesized triazenes complexed with novel gold (I): 1) [1,3-Bis (2-fluorophenyl) triazenido] (triphenylphosphine) gold (I); 2) [1,3-Bis (2- chlorophenyl) triazenido] (triphenylphosphine) gold (I) 3) [1,3-Bis (2-bromophenyl) triazenido] (triphenylphosphine) gold (I), 4) [1,3-Bis (2-iodophenyl) triazenido] (triphenylphosphine ) gold (I). Cytotoxicity of these compounds was evaluated by the MTT colorimetric assay of cell culture effecting bone marrow of patients with different types of leukemia, in addition to controlling patient without the disease. For the analysis of the antimicrobial activity was utilized quantitative methodology of microdilution with the determination of minimum inhibitory concentration (MIC). To determine the activity of nuclease cleavage assays were performed in double-stranded plasmid DNA using the method of electrophoresis in agarose gel. The results showed a considerable activity against different types of leukemia (acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia) with a small IC50 value of 0.0057 μmol mL-1 for compound 4 in cells of acute myeloid leukemia, all the active compounds in different types of leukemia but not so selective. The antibacterial activity was higher against gram-positive bacteria mainly in different strains of Staphylococcus aureus (MIC value of equal to 16 ug/ml). Any of the four compounds analyzed in this study was able to cleave the plasmid DNA. Thus, all tested triazenes have biological potential, or may be the subject of further studies as alternatives to anticancer and antimicrobial drugs existent.
id UFSM_8244881bc37317943b5aae38a109e9fc
oai_identifier_str oai:repositorio.ufsm.br:1/6012
network_acronym_str UFSM
network_name_str Biblioteca Digital de Teses e Dissertações do UFSM
repository_id_str
spelling 2015-10-272015-10-272013-03-22KEMPFER, Cláudia Barbisan. EVALUATION OF BIOLOGICAL ACTIVITY OF UNPUBLISHED TRIAZENES COMPLEXED WITH Au (I). 2013. 86 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2013.http://repositorio.ufsm.br/handle/1/6012The Triazenes are compounds with proven antibacterial and cytotoxic activity. Variations in the chemical structure such as complexation with metals like gold (I) can confer different biological activities. The antineoplastic temozolomide and dacarbazine are examples of commercially available triazenes used in the treatment of solid tumors and acute leukemias. In this study, the following compounds were synthesized triazenes complexed with novel gold (I): 1) [1,3-Bis (2-fluorophenyl) triazenido] (triphenylphosphine) gold (I); 2) [1,3-Bis (2- chlorophenyl) triazenido] (triphenylphosphine) gold (I) 3) [1,3-Bis (2-bromophenyl) triazenido] (triphenylphosphine) gold (I), 4) [1,3-Bis (2-iodophenyl) triazenido] (triphenylphosphine ) gold (I). Cytotoxicity of these compounds was evaluated by the MTT colorimetric assay of cell culture effecting bone marrow of patients with different types of leukemia, in addition to controlling patient without the disease. For the analysis of the antimicrobial activity was utilized quantitative methodology of microdilution with the determination of minimum inhibitory concentration (MIC). To determine the activity of nuclease cleavage assays were performed in double-stranded plasmid DNA using the method of electrophoresis in agarose gel. The results showed a considerable activity against different types of leukemia (acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia) with a small IC50 value of 0.0057 μmol mL-1 for compound 4 in cells of acute myeloid leukemia, all the active compounds in different types of leukemia but not so selective. The antibacterial activity was higher against gram-positive bacteria mainly in different strains of Staphylococcus aureus (MIC value of equal to 16 ug/ml). Any of the four compounds analyzed in this study was able to cleave the plasmid DNA. Thus, all tested triazenes have biological potential, or may be the subject of further studies as alternatives to anticancer and antimicrobial drugs existent.Os triazenos são compostos com comprovada atividade citotóxica e antibacteriana. Variações na sua estrutura química, como por exemplo a complexação com metais como o ouro (I), podem lhe conferir diferenciadas atividades biológicas. Os antineoplásicos dacarbazina e temozolomida constituem exemplos de triazenos disponíveis comercialmente utilizados no tratamento de tumores sólidos e leucemias agudas. Neste estudo foram sintetizados os seguintes compostos triazenos inéditos complexados com ouro (I): 1) [1,3- Bis(2-fluorofenil)triazenido](trifenilfosfina)ouro(I); 2) [1,3-Bis(2 clorofenil)triazenido] (trifenilfosfina)ouro(I); 3) [1,3-Bis(2-bromofenil)triazenido](trifenilfosfina)ouro(I); 4) [1,3- Bis(2 iodofenil)triazenido](trifenilfosfina)ouro(I). A citotoxicidade desses compostos foi avaliada através do ensaio colorimétrico do MTT efetuando cultura de células de medula óssea de pacientes com diferentes tipos de leucemias, além de paciente controle, sem a doença. Para a análise da atividade antimicrobiana foi utilizada a metodologia quantitativa da microdiluição em caldo com a determinação da concentração inibitória mínima (CIM). Para a determinação da atividade de nuclease foram efetuados ensaios de clivagem do DNA plasmidial fita dupla utilizando a metodologia de eletroforese em gel de agarose. Os resultados mostraram uma considerável atividade frente a diferentes tipos de leucemias (leucemia mielóide aguda, leucemia mielóide crônica, leucemia linfóide aguda, leucemia linfóide crônica) com um pequeno valor de IC50 de 0,0057 μmol mL-1 para o composto 4 em células de leucemia mielóide aguda, sendo todos os compostos ativos em diferentes tipos de leucemias, porém de forma não seletiva. A maior atividade antibacteriana foi frente a bactérias gram-positivas principalmente em diferentes cepas de Staphylococcus aureus (com valor de CIM igual a 16 ug/mL). Nenhum dos 4 compostos analisados nesse estudo conseguiu clivar o DNA plasmidial. Desta forma, todos os triazenos testados possuem potencial biológico, ou seja, podem ser objeto de mais estudos como alternativas aos fármacos antimicrobianos e antineoplásicos existentes.Conselho Nacional de Desenvolvimento Científico e Tecnológicoapplication/pdfporUniversidade Federal de Santa MariaPrograma de Pós-Graduação em Ciências FarmacêuticasUFSMBRAnálises Clínicas e ToxicológicasTriazenosOuroCitotoxicidadeS. aureusLeucemiaTriazenesGoldCytotoxicityS. aureusLeukemiaCNPQ::CIENCIAS DA SAUDE::FARMACIAAvaliação da atividade biológica de triazenos inéditos complexados com Au(I)Evaluation of biological activity of unpublished triazenes complexed with Au (I)info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisHorner, Rosmarihttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4707613Z5Krause, Luciana Maria Fontanarihttp://lattes.cnpq.br/9844890896121847Cóser, Virgínia Mariahttp://lattes.cnpq.br/4601008307298787http://lattes.cnpq.br/0787981293432612Kempfer, Cláudia Barbisan2010000000004003003003003005fdaffc5-abc5-4607-8952-fc5c4760b00432556794-40ea-47e1-88dc-2c2d0fd2531ca310dec0-114a-4a8c-836d-d08756d18299ce77d84d-25c9-4b42-90be-7a829ae7f940info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações do UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMORIGINALKEMPFER, CLAUDIA BARBISAN.pdfapplication/pdf2695915http://repositorio.ufsm.br/bitstream/1/6012/1/KEMPFER%2c%20CLAUDIA%20BARBISAN.pdff2ae0495e4ce24854c5ffe672c3fb64bMD51TEXTKEMPFER, CLAUDIA BARBISAN.pdf.txtKEMPFER, CLAUDIA BARBISAN.pdf.txtExtracted texttext/plain164555http://repositorio.ufsm.br/bitstream/1/6012/2/KEMPFER%2c%20CLAUDIA%20BARBISAN.pdf.txt7c9490f99f94209df2ddddfe71086b73MD52THUMBNAILKEMPFER, CLAUDIA BARBISAN.pdf.jpgKEMPFER, CLAUDIA BARBISAN.pdf.jpgIM Thumbnailimage/jpeg4975http://repositorio.ufsm.br/bitstream/1/6012/3/KEMPFER%2c%20CLAUDIA%20BARBISAN.pdf.jpg6041bfc696f8102fb97978fe4d019c7eMD531/60122022-10-14 16:12:14.172oai:repositorio.ufsm.br:1/6012Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2022-10-14T19:12:14Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Avaliação da atividade biológica de triazenos inéditos complexados com Au(I)
dc.title.alternative.eng.fl_str_mv Evaluation of biological activity of unpublished triazenes complexed with Au (I)
title Avaliação da atividade biológica de triazenos inéditos complexados com Au(I)
spellingShingle Avaliação da atividade biológica de triazenos inéditos complexados com Au(I)
Kempfer, Cláudia Barbisan
Triazenos
Ouro
Citotoxicidade
S. aureus
Leucemia
Triazenes
Gold
Cytotoxicity
S. aureus
Leukemia
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Avaliação da atividade biológica de triazenos inéditos complexados com Au(I)
title_full Avaliação da atividade biológica de triazenos inéditos complexados com Au(I)
title_fullStr Avaliação da atividade biológica de triazenos inéditos complexados com Au(I)
title_full_unstemmed Avaliação da atividade biológica de triazenos inéditos complexados com Au(I)
title_sort Avaliação da atividade biológica de triazenos inéditos complexados com Au(I)
author Kempfer, Cláudia Barbisan
author_facet Kempfer, Cláudia Barbisan
author_role author
dc.contributor.advisor1.fl_str_mv Horner, Rosmari
dc.contributor.advisor1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4707613Z5
dc.contributor.referee1.fl_str_mv Krause, Luciana Maria Fontanari
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/9844890896121847
dc.contributor.referee2.fl_str_mv Cóser, Virgínia Maria
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/4601008307298787
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/0787981293432612
dc.contributor.author.fl_str_mv Kempfer, Cláudia Barbisan
contributor_str_mv Horner, Rosmari
Krause, Luciana Maria Fontanari
Cóser, Virgínia Maria
dc.subject.por.fl_str_mv Triazenos
Ouro
Citotoxicidade
S. aureus
Leucemia
topic Triazenos
Ouro
Citotoxicidade
S. aureus
Leucemia
Triazenes
Gold
Cytotoxicity
S. aureus
Leukemia
CNPQ::CIENCIAS DA SAUDE::FARMACIA
dc.subject.eng.fl_str_mv Triazenes
Gold
Cytotoxicity
S. aureus
Leukemia
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE::FARMACIA
description The Triazenes are compounds with proven antibacterial and cytotoxic activity. Variations in the chemical structure such as complexation with metals like gold (I) can confer different biological activities. The antineoplastic temozolomide and dacarbazine are examples of commercially available triazenes used in the treatment of solid tumors and acute leukemias. In this study, the following compounds were synthesized triazenes complexed with novel gold (I): 1) [1,3-Bis (2-fluorophenyl) triazenido] (triphenylphosphine) gold (I); 2) [1,3-Bis (2- chlorophenyl) triazenido] (triphenylphosphine) gold (I) 3) [1,3-Bis (2-bromophenyl) triazenido] (triphenylphosphine) gold (I), 4) [1,3-Bis (2-iodophenyl) triazenido] (triphenylphosphine ) gold (I). Cytotoxicity of these compounds was evaluated by the MTT colorimetric assay of cell culture effecting bone marrow of patients with different types of leukemia, in addition to controlling patient without the disease. For the analysis of the antimicrobial activity was utilized quantitative methodology of microdilution with the determination of minimum inhibitory concentration (MIC). To determine the activity of nuclease cleavage assays were performed in double-stranded plasmid DNA using the method of electrophoresis in agarose gel. The results showed a considerable activity against different types of leukemia (acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia) with a small IC50 value of 0.0057 μmol mL-1 for compound 4 in cells of acute myeloid leukemia, all the active compounds in different types of leukemia but not so selective. The antibacterial activity was higher against gram-positive bacteria mainly in different strains of Staphylococcus aureus (MIC value of equal to 16 ug/ml). Any of the four compounds analyzed in this study was able to cleave the plasmid DNA. Thus, all tested triazenes have biological potential, or may be the subject of further studies as alternatives to anticancer and antimicrobial drugs existent.
publishDate 2013
dc.date.issued.fl_str_mv 2013-03-22
dc.date.accessioned.fl_str_mv 2015-10-27
dc.date.available.fl_str_mv 2015-10-27
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv KEMPFER, Cláudia Barbisan. EVALUATION OF BIOLOGICAL ACTIVITY OF UNPUBLISHED TRIAZENES COMPLEXED WITH Au (I). 2013. 86 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2013.
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/6012
identifier_str_mv KEMPFER, Cláudia Barbisan. EVALUATION OF BIOLOGICAL ACTIVITY OF UNPUBLISHED TRIAZENES COMPLEXED WITH Au (I). 2013. 86 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2013.
url http://repositorio.ufsm.br/handle/1/6012
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 201000000000
dc.relation.confidence.fl_str_mv 400
300
300
300
300
dc.relation.authority.fl_str_mv 5fdaffc5-abc5-4607-8952-fc5c4760b004
32556794-40ea-47e1-88dc-2c2d0fd2531c
a310dec0-114a-4a8c-836d-d08756d18299
ce77d84d-25c9-4b42-90be-7a829ae7f940
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências Farmacêuticas
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Análises Clínicas e Toxicológicas
publisher.none.fl_str_mv Universidade Federal de Santa Maria
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações do UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Biblioteca Digital de Teses e Dissertações do UFSM
collection Biblioteca Digital de Teses e Dissertações do UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/6012/1/KEMPFER%2c%20CLAUDIA%20BARBISAN.pdf
http://repositorio.ufsm.br/bitstream/1/6012/2/KEMPFER%2c%20CLAUDIA%20BARBISAN.pdf.txt
http://repositorio.ufsm.br/bitstream/1/6012/3/KEMPFER%2c%20CLAUDIA%20BARBISAN.pdf.jpg
bitstream.checksum.fl_str_mv f2ae0495e4ce24854c5ffe672c3fb64b
7c9490f99f94209df2ddddfe71086b73
6041bfc696f8102fb97978fe4d019c7e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1791086198811262976